Combining anti-PD-1/PD-L1 therapy with other immune checkpoint inhibitors, cancer vaccines and immune-stimulatory agents, chemotherapy, and radiotherapy has shown some success in various types of cancers 107, 108. The gene discussed is CD274; the disease is cancer.